BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15501808)

  • 1. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
    Badie G; Heithoff DM; Mahan MJ
    Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adenine methylase overproduction in Yersinia pseudotuberculosis alters YopE expression and secretion and host immune responses to infection.
    Julio SM; Heithoff DM; Sinsheimer RL; Low DA; Mahan MJ
    Infect Immun; 2002 Feb; 70(2):1006-9. PubMed ID: 11796641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
    Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes.
    Kubicek-Sutherland JZ; Heithoff DM; Ersoy SC; Shimp WR; Mahan MJ
    Vaccine; 2014 Mar; 32(13):1451-9. PubMed ID: 24508035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
    Monnazzi LG; Carlos IZ; de Medeiros BM
    Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Ca(2+) regulation of Yop secretion in Yersinia enterocolitica after DNA adenine methyltransferase overproduction is mediated by Clp-dependent degradation of LcrG.
    Fälker S; Schmidt MA; Heusipp G
    J Bacteriol; 2006 Oct; 188(20):7072-81. PubMed ID: 17015646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
    Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
    Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of outer membrane proteins of Yersinia pestis and Yersinia pseudotuberculosis strains isolated from India.
    Khushiramani R; Tuteja U; Shukla J; Batra HV
    Indian J Exp Biol; 2004 May; 42(5):508-14. PubMed ID: 15233478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA adenine methylase is essential for viability and plays a role in the pathogenesis of Yersinia pseudotuberculosis and Vibrio cholerae.
    Julio SM; Heithoff DM; Provenzano D; Klose KE; Sinsheimer RL; Low DA; Mahan MJ
    Infect Immun; 2001 Dec; 69(12):7610-5. PubMed ID: 11705940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.
    Bröms JE; Francis MS; Forsberg A
    J Bacteriol; 2007 Dec; 189(23):8417-29. PubMed ID: 17873031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
    Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
    Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
    Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
    J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the
    Daniel C; Dewitte A; Poiret S; Marceau M; Simonet M; Marceau L; Descombes G; Boutillier D; Bennaceur N; Bontemps-Gallo S; Lemaître N; Sebbane F
    Front Immunol; 2019; 10():1830. PubMed ID: 31428104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
    Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of Yersinia pestis with deletion of lcrG, a known negative regulator for Yop secretion of type III secretion system.
    Du Z; Tan Y; Yang H; Qiu J; Qin L; Wang T; Liu H; Bi Y; Song Y; Guo Z; Han Y; Zhou D; Wang X; Yang R
    Int J Med Microbiol; 2009 Jun; 299(5):355-66. PubMed ID: 19109068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
    Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
    Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Amino-Terminal Part of the Needle-Tip Translocator LcrV of
    Ekestubbe S; Bröms JE; Edgren T; Fällman M; Francis MS; Forsberg Å
    Front Cell Infect Microbiol; 2016; 6():175. PubMed ID: 27995096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.